Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non-small cell lung cancer after second-line chemotherapy treatment: A retrospective study. [electronic resource]
- Thoracic cancer 12 2018
- 1754-1762 p. digital